Accelerate Your Path to Clinical-Grade Cell Therapies
Advance your cell therapy with R&D Systems™-your trusted source for high‑quality reagents, assays, and workflow solutions that scale up from bench to GMP commercialization. Whether your cell therapy process development involves engineering autologous T cells for oncology, expanding NK cells for allogeneic cell therapy applications, or optimization of stem cell culture for regenerative medicine, we deliver lot‑to‑lot consistency, high purity, regulatory‑ready documentation, and end‑to‑end technical support to help your product development timelines move faster with confidence.
- Industry‑leading selection of RUO to GMP-grade cytokines, growth factors, antibodies, and immunoassays
- Robust quality control and quality assurance, with validation and traceability to meet FDA regulatory compliance for clinical trials and IND submissions
- Flexible solutions for closed, automated and scalable cell manufacturing processes
- Experience supporting customers in real time as they transition from translational to clinical manufacturing workflows
- GMP manufacturing facility with ISO 5/7/8 cleanrooms to ensure a reliable supply chain free from contamination
Immune Cell Therapy
Streamline Your Path to Clinic
Drive robust activation, expansion, and functional performance of your immune cell therapies with R&D Systems. From culture to analysis, our flexible animal-free GMP and closed‑system workflow solutions support reliable non-viral genome engineering, cell expansion and phenotype maintenance, while reducing risk and streamlining cGMP manufacturing, product characterization and regulatory approval.
Power your NK, TCR‑T, and CAR‑T cell therapy programs from preclinical research through clinical production with quality starting materials in process‑ready formats, plus analytical platform automation.
Regenerative Medicine
Improve Your Culture Consistency
Establish reproducible and scalable processes for your stem cell-based advanced therapies with R&D Systems. From first passage to final characterization, our animal-free GMP reagents, AI‑modified proteins, and new synthetic hydrogel support consistent expansion, lineage‑specific differentiation, and downstream biomanufacturing by minimizing variability and improving lot‑to‑lot reproducibility.
Partner with us from early-stage development to large-scale clinical manufacturing to accelerate your stem cell-based therapeutic programs.
R&D Systems believes in the power of partnerships. We have joined with Wilson Wolf to bring you ScaleReady™, lowering the barriers of entry into the immune cell therapy and biopharmaceutical space for all sizes and stages of manufacturing programs. ScaleReady brings cell and gene therapies to life by offering a significant reduction of complexity and cost while consistently providing superior repeatability and cell quality.
The ScaleReady product portfolio supports scalable solutions, delivering true platform, process, and product continuity for your immune cell programs. When paired with functionally-closed-system automated cell processing systems, R&D Systems reagents and the G-Rex® Bioreactor enable high throughput parallel bioprocessing of cell therapies within a small, cost-effective footprint.
Related Products
GMP Proteins
Cell Culture Media, Supplements, & Cryopreservation Solutions
TcBuster™ Non-Viral Gene Delivery
GMP Small Molecules
CellXVivo™ Immune Cell Differentiation and Expansion Kits
Stem Cell Kits and Panels
Multicolor Flow Cytometry Kits
Protein Analysis Analytical Instruments
RNAscope™ in situ Hybridization Assays
Proteome Profiler™ Antibody Arrays
Luminex® Assays and Luminex® High Performance Assays
Featured Resources
T Cell-Based Therapies eBook
An overview of the biological and manufacturing challenges facing T cell therapies at various process stages.
The CAR Toolkit Webinar
Learn about challenges, progress, and innovation in CAR T and CAR NK therapy development.
Cell Therapy Manufacturing Solutions
Pioneering manufacturing solutions for cell & gene therapy products, from discovery to the clinic.